OverviewSuggest Edit

    With one of the largest, most robust pipelines in the industry — including more than 120 research projects and product candidates — we comprise nearly half of AstraZeneca’s overall R&D portfolio. We are focused on three core therapeutic areas: Oncology; Respiratory, Inflammation and Autoimmune; and Cardiovascular and Metabolic Disease. But, we also are opportunity-driven in Infectious Disease.
    HQGaithersburg, US
    Employee Ratings3.7

    Latest Updates

    Employees (est.) (Sep 2019)3,163(-1%)

    Key People/Management at MedImmune

    Bahija Jallal

    Bahija Jallal

    President, MedImmune and Executive Vice President, AstraZeneca
    Matt Bell

    Matt Bell

    Scott Alban

    Scott Alban

    Vice President and Head of Global Intellectual Property
    Mohammed M. Dar

    Mohammed M. Dar

    Vice President & Head, Clinical Development, Oncology, MedImmune
    Jane Osbourn

    Jane Osbourn

    Vice President, R&D BioSuperiors and Site Leader; MedImmune Cambridge (UK)
    Tracy Rossin

    Tracy Rossin

    Head of Corporate Affairs, MedImmune
    Show more

    MedImmune Office Locations

    MedImmune has offices in Gaithersburg, Mountain View and Great Abington
    Gaithersburg, US (HQ)
    1 Medimmune Way
    Mountain View, US
    319 N Bernardo Ave
    Show all (3)

    MedImmune Financials and Metrics

    Summary Metrics

    Founding Date


    MedImmune Online and Social Media Presence

    Embed Graph

    MedImmune News and Updates

    Global Beta Nerve Growth Factor Market: Key Players are Astellas Pharma Inc, Fujimoto Pharmaceutical Corp, Krenitsky Pharmaceuticals Inc, MedImmune LLC, MimeTech Srl

    Beta Nerve Growth Factor Market report provides in-depth statistics and analysis available on the market status of the Beta Nerve Growth Factor Manufacturers and is a valuable method of obtaining guidance and direction for companies and business enterprise insider considering the Beta Nerve Growth F…

    Seasonal Influenza Vaccines Market Opportunities To 2026 Envisage By World's Key Players Sanofi S.A., CSL Limited, GlaxoSmithKline Plc., and Medimmune, LLC.

    #Summary: Summary This report includes market status and forecast of global and major regions, with the introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions. Posted via Industry Today. Follow us on Twi…

    AWIS Announces Life Sciences Trailblazer Dr. Susan Windham-Bannister as National Governing Board President

    WASHINGTON, July 31, 2018 /PRNewswire/ -- Susan Windham-Bannister, PhD, will serve as the new President of the Association for Women in Science's (AWIS) National Governing Board. AWIS is the leading organization that advocates for women in STEM. Dr. Windham-Bannister was elected by the...

    Michelson Prize Awards $450,000 to Young Scientists Advancing Immunology and Vaccine Research

    NEW YORK, June 19, 2018 /PRNewswire/ -- High risk, high reward scientific advancements require long-term flexible funding with a clear focus on transformative discoveries and approaches. The next generation of scientists are often the ones bringing innovative ideas and ground-breaking...
    Show more

    MedImmune Frequently Asked Questions

    • When was MedImmune founded?

      MedImmune was founded in 1987.

    • Who are MedImmune key executives?

      MedImmune's key executives are Bahija Jallal, Matt Bell and Scott Alban.

    • How many employees does MedImmune have?

      MedImmune has 3,163 employees.

    • Who are MedImmune competitors?

      Competitors of MedImmune include Organicell, Esperite and UNUM Therapeutics.

    • Where is MedImmune headquarters?

      MedImmune headquarters is located at 1 Medimmune Way, Gaithersburg.

    • Where are MedImmune offices?

      MedImmune has offices in Gaithersburg, Mountain View and Great Abington.

    • How many offices does MedImmune have?

      MedImmune has 3 offices.